SC 13D Filing

Company

Aptose Biosciences Inc.

Filed

August 2, 2007

Accession Number

0001178913-07-001627

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →